Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1228

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 8
Chunk 1228
---
”) pay. This disclosure is
intended to comply with the requirements of Item 402(v) of Regulation S-K applicable to “smaller reporting companies.” For
additional information about our compensation philosophy and how we seek to align executive compensation with the Company’s performance,
refer to “Executive and Director Compensation” section above.

Required Tabular Disclosure of Pay Versus Performance

The
amounts set forth below under the headings “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid
to Non-PEO NEOs” have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term “compensation
actually paid” is required by the SEC’s rules and as a result of the calculation methodology required by the SEC, such amounts
differ from compensation actually received by the individuals and the compensation decisions described in the “Executive and Director
Compensation” section above. With the exception of Charles J. Fisher as PEO during the 2023 fiscal year, our Chief Executive Officer
is our principal executive officer and is referred to as PEO in the headers in the following tables.

     PAY VERSUS PERFORMANCE 
  
     Fiscal
                                            Year  
     Summary
                                            Compensation Table Total for PEO 1(1) ($)  
     Compensation
                                            Actually Paid to PEO 1(2)(4) ($)  
     Summary
                                            Compensation Table Total for PEO 2(1) ($)  
     Compensation
                                            Actually Paid to PEO 2(3)(4) ($)  
     Average
                                            Summary Compensation Table Total for Non-PEO NEOs(5) ($)  
     Average
                                            Compensation Actually Paid to Non-PEO NEOs(6) ($)  
     Value
                                            of Initial Fixed $100 Investment Based On Total Shareholder Return(7) ($)  
     Net
                                            Income (Loss) (millions)(8) ($) 
  
     (a)  
     (b)  
     (c)  
     (b)  
     (c)  
     (d)  
     (e)  
     (f)  
     (h) 
  
     2025  
    $–  
    $–  
    $500,000  
    $495,402  
    $430,844  
    $430,875